Peptides · Peptide comparison
Acetyl Hexapeptide-3 (Argireline) vs Myristoyl Pentapeptide-17
SNARE complex inhibitor that reduces expression wrinkles through topical neuromuscular modulation — the 'Botox in a bottle' peptide.
Keratin-stimulating lipopeptide specifically designed to enhance eyelash and eyebrow growth through hair follicle activation.
- Cosmetic
- Cosmetic
At a glance
Quick comparison
Efficacy
Benefit ratings
Expression Wrinkle Reduction
Non-Invasive Treatment
Safety Profile
Eyelash Growth
Hair Strengthening
Technical data
Compound specifications
Acetyl Hexapeptide-3 (Argireline)
- Molecular formula
- C35H62N14O11S
- Molecular weight
- 887.0 Da
- Half-life
- Topical stability dependent on formulation; methionine residue susceptible to oxidation; stable at pH 5.5-7.7
- Bioavailability
- Limited skin penetration (0.22-0.54%); primarily acts at stratum corneum and superficial epidermis; O/W emulsions enhance delivery
- CAS number
- 616204-22-9
Myristoyl Pentapeptide-17
- Molecular formula
- C41H81N9O6
- Molecular weight
- 796.2 Da
- Half-life
- Topical application; sustained follicular activity with daily reapplication
- Bioavailability
- Enhanced follicular penetration via myristic acid (C14) lipid conjugation
- CAS number
- 959610-30-1
Protocols
Dosing compared
Acetyl Hexapeptide-3 (Argireline)
Topical
- 5-10% concentration (cream or serum)Twice daily (morning and evening) · Minimum 28-30 days; ongoing use to maintain effectUsed as a leave-on skin cream or serum. In studies, a 10% formula applied twice a day around the eyes reduced wrinkle depth by about 17% after 15 days and up to 27-30% after 30 days. It works on the skin surface only and is not injected. [1][2]
Myristoyl Pentapeptide-17
Topical
- 0.001-0.1% in finished serum (supplied as a 0.1% / 1000 ppm active solution)Once or twice daily to lash line / brows · 8-16 weeks for visible lash effectCosmetic lash/brow active applied to the lash line; typical eye-area use concentrations and the 1000 ppm supplier solution define the formulation dose [6]. Topical only; not dosed systemically.
Applications
Best suited for
Acetyl Hexapeptide-3 (Argireline)
- Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
- Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals seeking non-invasive reduction of expression lines and dynamic wrinkles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1][4].
- Those with needle phobia who want botulinum toxin-like effects without injections
- Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on those with needle phobia who want botulinum toxin-like effects without injections. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [4].
- People targeting crow's feet, forehead lines, and glabellar creases
- Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on people targeting crow's feet, forehead lines, and glabellar creases. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Individuals looking for preventive anti-wrinkle treatment to slow expression line formation
- Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals looking for preventive anti-wrinkle treatment to slow expression line formation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Myristoyl Pentapeptide-17
- Individuals seeking longer, fuller eyelashes without prostaglandin-based prescriptions
- Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on individuals seeking longer, fuller eyelashes without prostaglandin-based prescriptions. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Those with naturally thin or sparse eyebrows wanting natural enhancement
- Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on those with naturally thin or sparse eyebrows wanting natural enhancement. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- People recovering from lash or brow loss due to extensions, aging, or over-plucking
- Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on people recovering from lash or brow loss due to extensions, aging, or over-plucking. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Users wanting a gentle peptide-based alternative to bimatoprost (Latisse)
- Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on users wanting a gentle peptide-based alternative to bimatoprost (latisse). Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Safety profile
Side effects
Acetyl Hexapeptide-3 (Argireline)
Common
- Mild Skin Irritation
- Transient Redness
- Slight Dryness
- Stinging on Compromised Skin
Uncommon
- Contact Dermatitis
Serious
- Allergic Contact Dermatitis
Myristoyl Pentapeptide-17
Common
- Mild Tingling at Lash Line
- Temporary Eyelid Dryness
- Product Residue Buildup
- Lash Shedding During Initial Phase
Uncommon
- Periorbital Sensitivity
Serious
- Allergic Contact Reaction
- Lipid Peroxidation and Oxidative Stress
Research status
Safety & evidence
Acetyl Hexapeptide-3 (Argireline)
- Evidence level
- Limited human trials
- FDA status
- Research compound
- Safety overview
- Acetyl Hexapeptide-3 demonstrates an excellent safety profile for topical cosmetic use with no serious adverse events reported in clinical studies. At the 10% concentrations used in cosmetic formulations, systemic absorption is minimal and no neurotoxicity has been observed despite its mechanism of action on the neuromuscular junction. In cell-culture testing, significant cytotoxicity appeared only at concentrations 18 to 10,000 times higher than the reference drug doxorubicin [5]. Primary concerns are limited to local skin irritation in sensitive individuals, such as mild erythema, transient stinging, or contact dermatitis in those with peptide hypersensitivity.
Contraindications
- Known hypersensitivity to acetyl hexapeptide-3 or formulation components
- Active skin infections or open wounds at the application site
- No known systemic contraindications at cosmetic concentrations
- Use with caution in individuals with neuromuscular disorders (theoretical concern)
Myristoyl Pentapeptide-17
- Evidence level
- Limited human trials
- FDA status
- Research compound
- Safety overview
- Myristoyl pentapeptide-17 demonstrates excellent cosmetic safety with GRAS/safe-for-use status in topical formulations up to 3% concentration. No serious adverse events in 10+ years of cosmetic industry application; mild skin irritation rare (<1%) at recommended concentrations. Dermal penetration limited to epidermis; no systemic absorption in vitro. Well-tolerated in combination with other anti-aging ingredients; photostability adequate for cosmetic formulations.
Contraindications
- Known hypersensitivity to myristoylated peptides or formulation components
- Active eye infections, styes, or periorbital dermatitis
- Post-surgical eye conditions where topical application is contraindicated
- Concurrent use of prescription eyelash growth products without medical guidance
Decision guide
Which is right for you?
Acetyl Hexapeptide-3 (Argireline)
Choose Acetyl Hexapeptide-3 (Argireline) if…
- Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
- Those with needle phobia who want botulinum toxin-like effects without injections
- People targeting crow's feet, forehead lines, and glabellar creases
- Individuals looking for preventive anti-wrinkle treatment to slow expression line formation
Myristoyl Pentapeptide-17
Choose Myristoyl Pentapeptide-17 if…
- Individuals seeking longer, fuller eyelashes without prostaglandin-based prescriptions
- Those with naturally thin or sparse eyebrows wanting natural enhancement
- People recovering from lash or brow loss due to extensions, aging, or over-plucking
- Users wanting a gentle peptide-based alternative to bimatoprost (Latisse)